232 related articles for article (PubMed ID: 24363525)
1. Clinical significance of serum procalcitonin in patients with ulcerative colitis.
Koido S; Ohkusa T; Takakura K; Odahara S; Tsukinaga S; Yukawa T; Mitobe J; Kajihara M; Uchiyama K; Arakawa H; Tajiri H
World J Gastroenterol; 2013 Dec; 19(45):8335-41. PubMed ID: 24363525
[TBL] [Abstract][Full Text] [Related]
2. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
[TBL] [Abstract][Full Text] [Related]
4. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis.
Kocazeybek B; Küçükoğlu S; Oner YA
Chemotherapy; 2003 May; 49(1-2):76-84. PubMed ID: 12714816
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
7. High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population.
Liu W; Sigdel KR; Wang Y; Su Q; Huang Y; Zhang YL; Chen J; Duan L; Shi G
PLoS One; 2015; 10(7):e0132855. PubMed ID: 26182343
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
9. Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease.
Oussalah A; Laurent V; Bruot O; Guéant JL; Régent D; Bigard MA; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1135-44. PubMed ID: 21039675
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis.
Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I
J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Serum Total Bilirubin in Predicting the Severity of Ulcerative Colitis: A Cross-Sectional Study.
Zhang MH; Wang HG; Shi YT; Zhou JF; Yan W; Ma TH; Wu SN; Yang XZ
Ann Clin Lab Sci; 2020 Mar; 50(2):228-232. PubMed ID: 32366561
[TBL] [Abstract][Full Text] [Related]
14. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates.
Claeys R; Vinken S; Spapen H; ver Elst K; Decochez K; Huyghens L; Gorus FK
Crit Care Med; 2002 Apr; 30(4):757-62. PubMed ID: 11940741
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
17. Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.
Hosomi S; Yamagami H; Itani S; Yukawa T; Otani K; Nagami Y; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
J Crohns Colitis; 2018 Jan; 12(1):87-95. PubMed ID: 28961693
[TBL] [Abstract][Full Text] [Related]
18. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin: a valuable indicator of infection in a medical ICU?
Suprin E; Camus C; Gacouin A; Le Tulzo Y; Lavoue S; Feuillu A; Thomas R
Intensive Care Med; 2000 Sep; 26(9):1232-8. PubMed ID: 11089747
[TBL] [Abstract][Full Text] [Related]
20. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
